• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Medical Properties Trust, Inc. Reports Second Quarter Results

    8/8/24 8:00:00 AM ET
    $MPW
    Real Estate Investment Trusts
    Real Estate
    Get the next $MPW alert in real time by email

    Successfully Executed More than $2.5 Billion in Year-to-Date Liquidity Transactions

    Modified Credit Facility Terms and Conditions

    Medical Properties Trust, Inc. (the "Company" or "MPT") (NYSE:MPW) today announced financial and operating results for the second quarter ended June 30, 2024, as well as certain events occurring subsequent to quarter end.

    Second Quarter Financial Highlights

    • Net loss of ($0.54) and Normalized Funds from Operations ("NFFO") of $0.23 for the 2024 second quarter on a per share basis;
    • Second quarter net loss included approximately $400 million in real estate gains, offset by approximately $700 million in impairments and negative fair value adjustments.

    Corporate Updates During and Subsequent to the Second Quarter

    • Closed on the sale of five previously leased hospitals to Prime Healthcare for total consideration of $350 million in April;
    • Closed on the sale of a 75% interest in five Utah hospitals leased to CommonSpirit to a new joint venture with an institutional investor in April for total proceeds of $1.1 billion;
    • Completed a £631 million (~$800 million) secured financing of 27 U.K. hospitals leased to Circle Health in May;
    • Sold for approximately $160 million seven freestanding emergency department ("FSED") facilities as well as one general acute hospital in Arizona to Dignity Health in July;
    • Repaid approximately $1.5 billion in debt, including all 2024 maturities; and
    • Paid a regular quarterly dividend of $0.15 per share.

    Edward K. Aldag, Jr., Chairman, President and Chief Executive Officer, said, "MPT took decisive action to generate more than $2.5 billion of liquidity year-to-date – well above our initial target for the year – as well as to expedite debt paydown. The vast majority of our portfolio continues to perform well, and we remain focused on executing our strategy to demonstrate the tremendous value embedded in our platform."

    Included in the financial tables accompanying this press release is information about the Company's assets and liabilities, operating results, and reconciliations of net loss to NFFO, including per share amounts, all on a basis comparable to 2023 results.

    CAPITAL ALLOCATION UPDATE

    Subsequent to the end of the quarter, MPT amended its credit facility to reflect recent disposition and financing transactions and better align with the Company's current capital allocation strategy, as well as to accommodate the expected timing of sales and re-tenanting transactions that Steward Health Care ("Steward") is pursuing through its court-supervised restructuring process.

    The amendment includes the reduction of MPT's revolver commitment from $1.4 billion to $1.28 billion, a permanent resetting of the facility's consolidated net worth covenant from approximately $6.7 billion to $5.0 billion, and modifications to certain other covenants through September 30, 2025. In addition, MPT has agreed to limit the cash component of total quarterly dividends to no more than $0.08 per share. In the event that Steward's hospital operations are transitioned to other operators more rapidly, the Company has the right to terminate the amendment provisions earlier than September 30, 2025.

    PORTFOLIO UPDATE

    Medical Properties Trust has total assets of approximately $16.2 billion, including $10.0 billion of general acute facilities, $2.4 billion of behavioral health facilities and $1.7 billion of post-acute facilities. As of June 30, 2024, MPT's portfolio included 435 properties and approximately 42,000 licensed beds leased to or mortgaged by 53 hospital operating companies across the United States as well as in the United Kingdom, Switzerland, Germany, Spain, Finland, Colombia, Italy and Portugal.

    MPT's European general acute portfolio continues to benefit from the broadening role of private hospitals in addressing rapidly growing care needs, particularly in the U.K. Further, increasing reimbursement rates and acuity levels have largely kept pace with ongoing expense pressures. Swiss Medical Network is reporting success in broadening its presence in Switzerland by successfully marketing new integrated care programs. Behavioral and post-acute operations have remained consistent, with MEDIAN reporting increasing occupancy and profit margins and Priory continuing to execute its plans in the U.K. to meet market demands for more high-acuity services.

    In the Company's U.S. portfolio, excluding facilities operated by Steward and Prospect Medical Holdings ("Prospect"), general acute revenue trends are strong and benefitting from higher admissions, acuity mix and reimbursement rates, while the behavioral segment is reporting steady growth in volumes and moderating expenses. Most notably, MPT's portfolio of general acute hospitals operated by Lifepoint Health recorded its highest total admissions in nearly three years in the first quarter and continues to see increasing profitability. Overall performance of the post-acute segment, which combines inpatient rehabilitation ("IRF") and long-term acute care ("LTACH") facilities, remained stable with strong performance across well-established IRF properties offsetting the anticipated ramping of operations at newly developed IRF properties.

    As expected, Steward paid May and June cash rent of approximately $19 million with respect to the consolidated master lease and remained current on its obligations to the Company's Massachusetts partnership with Macquarie Asset Management (together with its affiliates, "Macquarie"). Steward also made July payments as scheduled for all leased facilities.

    Due to unanticipated restrictions imposed by regulators that impacted the process of transitioning ownership of eight hospitals operated by Steward in Massachusetts, MPT – which owns a 50% interest in these properties through a partnership that has a separate master lease agreement with Steward – expects to relinquish its ownership of those properties to the non-recourse secured lender. As a result, MPT has fully impaired its equity investment in the partnership. The NFFO contribution of the joint venture in the second quarter was approximately $7 million, or $0.01 per diluted share.

    During the second quarter of 2024, Prospect paid cash rent of $18 million and cash interest of $4 million, fully satisfying past-due amounts from the first quarter as well as all amounts due in the second quarter.

    OPERATING RESULTS

    Net loss for the second quarter ended June 30, 2024 was ($321 million), or ($0.54) per share, compared to net loss of ($42 million), or ($0.07) per share, in the year earlier period. Net loss for the quarter ended June 30, 2024 included approximately $400 million in real estate gains resulting from joint venture and asset sales transactions as well as approximately $700 million in impairments and negative fair value adjustments that primarily included:

    • The impairment of MPT's approximate $400 million equity stake in the Massachusetts partnership with Macquarie (included on the income statement in earnings from equity interests); and
    • A $163 million negative fair market value adjustment to the Company's investment in PHP due to changes in third-party valuations and other discounting assumptions.

    NFFO for the second quarter ended June 30, 2024 was $139 million, or $0.23 per share, compared to $285 million, or $0.48 per share in the year earlier period.

    A reconciliation of net loss to FFO and NFFO, including per share amounts, can be found in the financial tables accompanying this press release.

    CONFERENCE CALL AND WEBCAST

    The Company has scheduled a conference call and webcast for August 8, 2024 at 11:00 a.m. Eastern Time to present the Company's financial and operating results for the quarter ended June 30, 2024. The dial-in numbers for the conference call are 877-883-0383 (U.S.) and 412-902-6506 (International) along with passcode 1112764. The conference call will also be available via webcast in the Investor Relations section of the Company's website, www.medicalpropertiestrust.com.

    A telephone and webcast replay of the call will be available beginning shortly after the call's completion. The telephone replay will be available through August 22, 2024, using dial-in numbers 877-344-7529 (U.S.), 855-669-9658 (Canada) and 412-317-0088 (International) along with passcode 6602146. The webcast replay will be available for one year following the call's completion on the Investor Relations section of the Company's website.

    The Company's supplemental information package for the current period will also be available on the Company's website in the Investor Relations section.

    The Company uses, and intends to continue to use, the Investor Relations page of its website, which can be found at www.medicalpropertiestrust.com, as a means of disclosing material nonpublic information and of complying with its disclosure obligations under Regulation FD, including, without limitation, through the posting of investor presentations that may include material nonpublic information. Accordingly, investors should monitor the Investor Relations page, in addition to following our press releases, SEC filings, public conference calls, presentations and webcasts. The information contained on, or that may be accessed through, our website is not incorporated by reference into, and is not a part of, this document.

    About Medical Properties Trust, Inc.

    Medical Properties Trust, Inc. is a self-advised real estate investment trust formed in 2003 to acquire and develop net-leased hospital facilities. From its inception in Birmingham, Alabama, the Company has grown to become one of the world's largest owners of hospital real estate with 435 facilities and approximately 42,000 licensed beds in nine countries and across three continents as of June 30, 2024. MPT's financing model facilitates acquisitions and recapitalizations and allows operators of hospitals to unlock the value of their real estate assets to fund facility improvements, technology upgrades and other investments in operations. For more information, please visit the Company's website at www.medicalpropertiestrust.com.

    Forward-Looking Statements

    This press release includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Forward-looking statements can generally be identified by the use of forward-looking words such as "may", "will", "would", "could", "expect", "intend", "plan", "estimate", "target", "anticipate", "believe", "objectives", "outlook", "guidance" or other similar words, and include statements regarding our strategies, objectives, asset sales and other liquidity transactions (including the use of proceeds thereof), expected returns on investments and financial performance, expected trends and performance across our various markets, and expected outcomes from Steward's restructuring process. Forward-looking statements involve known and unknown risks and uncertainties that may cause our actual results or future events to differ materially from those expressed in or underlying such forward-looking statements, including, but not limited to: (i) the risk that the bankruptcy restructuring of Steward, the Company's largest tenant, does not result in MPT recovering deferred rent or its other investments in Steward at full value, within a reasonable time period or at all; (ii) macroeconomic conditions, including due to geopolitical conditions and instability, which may lead to a disruption of or lack of access to the capital markets, disruptions and instability in the banking and financial services industries, rising inflation and movements in currency exchange rates; (iii) the risk that previously announced or contemplated property sales, loan repayments, and other capital recycling transactions do not occur as anticipated or at all; (iv) the risk that MPT is not able to attain its leverage, liquidity and cost of capital objectives within a reasonable time period or at all; (v) MPT's ability to obtain debt financing on attractive terms or at all, as a result of changes in interest rates and other factors, which may adversely impact its ability to pay down, refinance, restructure or extend its indebtedness as it becomes due, or pursue acquisition and development opportunities; (vi) the ability of our tenants, operators and borrowers to satisfy their obligations under their respective contractual arrangements with us; (vii) the economic, political and social impact of, and uncertainty relating to, the potential impact from health crises (like COVID-19), which may adversely affect MPT's and its tenants' business, financial condition, results of operations and liquidity; (viii) our success in implementing our business strategy and our ability to identify, underwrite, finance, consummate and integrate acquisitions and investments; (ix) the nature and extent of our current and future competition; (x) international, national and local economic, real estate and other market conditions, which may negatively impact, among other things, the financial condition of our tenants, lenders and institutions that hold our cash balances, and may expose us to increased risks of default by these parties; (xi) factors affecting the real estate industry generally or the healthcare real estate industry in particular; (xii) our ability to maintain our status as a REIT for income tax purposes in the U.S. and U.K.; (xiii) federal and state healthcare and other regulatory requirements, as well as those in the foreign jurisdictions where we own properties; (xiv) the value of our real estate assets, which may limit our ability to dispose of assets at attractive prices or obtain or maintain equity or debt financing secured by our properties or on an unsecured basis; (xv) the ability of our tenants and operators to operate profitably and generate positive cash flow, remain solvent, comply with applicable laws, rules and regulations in the operation of our properties, to deliver high-quality services, to attract and retain qualified personnel and to attract patients; (xvi) potential environmental contingencies and other liabilities; (xvii) the risk that expected asset sales do not occur at the agreed upon terms or at all; (xviii) the risk that we are unable to monetize our investments in certain tenants at full value within a reasonable time period or at all; (xix) the cooperation of our joint venture partners, including adverse developments affecting the financial health of such joint venture partners or the joint venture itself; and (xx) the risks and uncertainties of litigation or other regulatory proceedings.

    The risks described above are not exhaustive and additional factors could adversely affect our business and financial performance, including the risk factors discussed under the section captioned "Risk Factors" in our most recent Annual Report on Form 10-K and our Form 10-Q, and as may be updated in our other filings with the SEC. Forward-looking statements are inherently uncertain and actual performance or outcomes may vary materially from any forward-looking statements and the assumptions on which those statements are based. Readers are cautioned to not place undue reliance on forward-looking statements as predictions of future events. We disclaim any responsibility to update such forward-looking statements, which speak only as of the date on which they were made.

    MEDICAL PROPERTIES TRUST, INC. AND SUBSIDIARIES
     
    Consolidated Balance Sheets
    (Amounts in thousands, except for per share data)
    June 30, 2024 December 31, 2023
    Assets (Unaudited) (A)
    Real estate assets
    Land, buildings and improvements, intangible lease assets, and other

    $

    11,949,385

     

    $

    13,237,187

     

    Investment in financing leases

     

    1,181,959

     

     

    1,231,630

     

    Mortgage loans

     

    399,150

     

     

    309,315

     

    Gross investment in real estate assets

     

    13,530,494

     

     

    14,778,132

     

    Accumulated depreciation and amortization

     

    (1,417,910

    )

     

    (1,407,971

    )

    Net investment in real estate assets

     

    12,112,584

     

     

    13,370,161

     

     
    Cash and cash equivalents

     

    606,550

     

     

    250,016

     

    Interest and rent receivables

     

    39,471

     

     

    45,059

     

    Straight-line rent receivables

     

    664,271

     

     

    635,987

     

    Investments in unconsolidated real estate joint ventures

     

    1,143,231

     

     

    1,474,455

     

    Investments in unconsolidated operating entities

     

    635,206

     

     

    1,778,640

     

    Other loans

     

    505,942

     

     

    292,615

     

    Other assets

     

    487,488

     

     

    457,911

     

    Total Assets

    $

    16,194,743

     

    $

    18,304,844

     

     
    Liabilities and Equity
    Liabilities
    Debt, net

    $

    9,369,064

     

    $

    10,064,236

     

    Accounts payable and accrued expenses

     

    446,893

     

     

    412,178

     

    Deferred revenue

     

    25,700

     

     

    37,962

     

    Obligations to tenants and other lease liabilities

     

    160,009

     

     

    156,603

     

    Total Liabilities

     

    10,001,666

     

     

    10,670,979

     

     
    Equity
    Preferred stock, $0.001 par value. Authorized 10,000 shares; no shares outstanding

     

    -

     

     

    -

     

    Common stock, $0.001 par value. Authorized 750,000 shares; issued and outstanding - 600,057 shares at June 30, 2024 and 598,991 shares at December 31, 2023

     

    600

     

     

    599

     

    Additional paid-in capital

     

    8,571,662

     

     

    8,560,309

     

    Retained deficit

     

    (2,348,170

    )

     

    (971,809

    )

    Accumulated other comprehensive (loss) income

     

    (33,910

    )

     

    42,501

     

    Total Medical Properties Trust, Inc. Stockholders' Equity

     

    6,190,182

     

     

    7,631,600

     

     
    Non-controlling interests

     

    2,895

     

     

    2,265

     

    Total Equity

     

    6,193,077

     

     

    7,633,865

     

    Total Liabilities and Equity

    $

    16,194,743

     

    $

    18,304,844

     

     
    (A) Financials have been derived from the prior year audited financial statements.
    MEDICAL PROPERTIES TRUST, INC. AND SUBSIDIARIES
     
    Consolidated Statements of Income
    (Unaudited)
     
    (Amounts in thousands, except for per share data) For the Three Months Ended For the Six Months Ended
    June 30, 2024 June 30, 2023 June 30, 2024 June 30, 2023
     
    Revenues
    Rent billed

    $

    183,764

     

    $

    247,491

     

    $

    383,063

     

    $

    495,648

     

    Straight-line rent

     

    38,381

     

     

    (39,329

    )

     

    83,117

     

     

    17,364

     

    Income from financing leases

     

    27,641

     

     

    68,468

     

     

    44,034

     

     

    81,663

     

    Interest and other income

     

    16,774

     

     

    60,765

     

     

    27,662

     

     

    92,931

     

    Total revenues

     

    266,560

     

     

    337,395

     

     

    537,876

     

     

    687,606

     

     
    Expenses
    Interest

     

    101,430

     

     

    104,470

     

     

    210,115

     

     

    202,124

     

    Real estate depreciation and amortization

     

    102,240

     

     

    364,403

     

     

    177,826

     

     

    448,263

     

    Property-related (A)

     

    7,663

     

     

    24,676

     

     

    12,481

     

     

    31,786

     

    General and administrative

     

    35,327

     

     

    35,604

     

     

    68,675

     

     

    77,328

     

    Total expenses

     

    246,660

     

     

    529,153

     

     

    469,097

     

     

    759,501

     

     
    Other (expense) income
    Gain on sale of real estate

     

    384,824

     

     

    167

     

     

    383,401

     

     

    229

     

    Real estate and other impairment charges, net

     

    (137,419

    )

     

    -

     

     

    (830,507

    )

     

    (89,538

    )

    (Loss) earnings from equity interests

     

    (401,757

    )

     

    12,224

     

     

    (391,208

    )

     

    23,576

     

    Debt refinancing and unutilized financing costs

     

    (2,964

    )

     

    (816

    )

     

    (2,964

    )

     

    (816

    )

    Other (including fair value adjustments on securities)

     

    (167,686

    )

     

    (10,512

    )

     

    (397,031

    )

     

    (15,678

    )

    Total other (expense) income

     

    (325,002

    )

     

    1,063

     

     

    (1,238,309

    )

     

    (82,227

    )

     
    Loss before income tax

     

    (305,102

    )

     

    (190,695

    )

     

    (1,169,530

    )

     

    (154,122

    )

     
    Income tax (expense) benefit

     

    (14,557

    )

     

    148,262

     

     

    (25,506

    )

     

    144,719

     

     
    Net loss

     

    (319,659

    )

     

    (42,433

    )

     

    (1,195,036

    )

     

    (9,403

    )

    Net (income) loss attributable to non-controlling interests

     

    (976

    )

     

    396

     

     

    (1,224

    )

     

    160

     

    Net loss attributable to MPT common stockholders

    $

    (320,635

    )

    $

    (42,037

    )

    $

    (1,196,260

    )

    $

    (9,243

    )

     
    Earnings per common share - basic and diluted:
    Net loss attributable to MPT common stockholders

    $

    (0.54

    )

    $

    (0.07

    )

    $

    (1.99

    )

    $

    (0.02

    )

     
    Weighted average shares outstanding - basic

     

    600,057

     

     

    598,344

     

     

    600,181

     

     

    598,323

     

    Weighted average shares outstanding - diluted

     

    600,057

     

     

    598,344

     

     

    600,181

     

     

    598,323

     

     
    Dividends declared per common share

    $

    0.30

     

    $

    0.29

     

    $

    0.30

     

    $

    0.58

     

     
    (A) Includes $4.9 million and $21.1 million of ground lease and other expenses (such as property taxes and insurance) paid directly by us and reimbursed by our tenants for the three months ended June 30, 2024 and 2023, respectively, and $7.2 million and $25.3 million for the six months ended June 30, 2024 and 2023, respectively.
    MEDICAL PROPERTIES TRUST, INC. AND SUBSIDIARIES
     
    Reconciliation of Net Loss to Funds From Operations
    (Unaudited)
     
    (Amounts in thousands, except for per share data) For the Three Months Ended For the Six Months Ended
    June 30, 2024 June 30, 2023 June 30, 2024 June 30, 2023
     
    FFO information:
    Net loss attributable to MPT common stockholders

    $

    (320,635

    )

    $

    (42,037

    )

    $

    (1,196,260

    )

    $

    (9,243

    )

    Participating securities' share in earnings

     

    (654

    )

     

    (469

    )

     

    (654

    )

     

    (984

    )

    Net loss, less participating securities' share in earnings

    $

    (321,289

    )

    $

    (42,506

    )

    $

    (1,196,914

    )

    $

    (10,227

    )

     
    Depreciation and amortization

     

    117,239

     

     

    382,244

     

     

    211,482

     

     

    484,204

     

    Gain on sale of real estate

     

    (384,824

    )

     

    (167

    )

     

    (383,401

    )

     

    (229

    )

    Real estate impairment charges

     

    499,324

     

     

    -

     

     

    499,324

     

     

    52,104

     

    Funds from operations

    $

    (89,550

    )

    $

    339,571

     

    $

    (869,509

    )

    $

    525,852

     

     
    Write-off of billed and unbilled rent and other

     

    1,188

     

     

    95,642

     

     

    3,005

     

     

    135,268

     

    Other impairment charges, net

     

    48,885

     

     

    -

     

     

    741,973

     

     

    -

     

    Litigation and other

     

    11,738

     

     

    2,502

     

     

    17,608

     

     

    10,228

     

    Share-based compensation adjustments

     

    -

     

     

    (4,363

    )

     

    -

     

     

    (4,363

    )

    Non-cash fair value adjustments

     

    159,247

     

     

    8,374

     

     

    380,523

     

     

    4,253

     

    Tax rate changes and other

     

    4,895

     

     

    (157,230

    )

     

    4,588

     

     

    (164,535

    )

    Debt refinancing and unutilized financing costs

     

    2,964

     

     

    816

     

     

    2,964

     

     

    816

     

    Normalized funds from operations

    $

    139,367

     

    $

    285,312

     

    $

    281,152

     

    $

    507,519

     

     
    Certain non-cash and related recovery information:
    Share-based compensation

    $

    8,521

     

    $

    10,800

     

    $

    16,154

     

    $

    22,629

     

    Debt costs amortization

    $

    4,936

     

    $

    5,203

     

    $

    9,775

     

    $

    10,324

     

    Non-cash rent and interest revenue (A)

    $

    -

     

    $

    (129,494

    )

    $

    -

     

    $

    (150,357

    )

    Cash recoveries of non-cash rent and interest revenue (B)

    $

    540

     

    $

    2,380

     

    $

    6,288

     

    $

    33,736

     

    Straight-line rent revenue from operating and finance leases

    $

    (40,786

    )

    $

    (60,825

    )

    $

    (88,032

    )

    $

    (123,414

    )

     
     
    Per diluted share data:
    Net loss, less participating securities' share in earnings

    $

    (0.54

    )

    $

    (0.07

    )

    $

    (1.99

    )

    $

    (0.02

    )

    Depreciation and amortization

     

    0.20

     

     

    0.64

     

     

    0.35

     

     

    0.81

     

    Gain on sale of real estate

     

    (0.64

    )

     

    -

     

     

    (0.64

    )

     

    -

     

    Real estate impairment charges

     

    0.83

     

     

    -

     

     

    0.83

     

     

    0.09

     

    Funds from operations

    $

    (0.15

    )

    $

    0.57

     

    $

    (1.45

    )

    $

    0.88

     

     
    Write-off of billed and unbilled rent and other

     

    -

     

     

    0.16

     

     

    0.01

     

     

    0.23

     

    Other impairment charges, net

     

    0.08

     

     

    -

     

     

    1.24

     

     

    -

     

    Litigation and other

     

    0.02

     

     

    -

     

     

    0.03

     

     

    0.01

     

    Share-based compensation adjustments

     

    -

     

     

    -

     

     

    -

     

     

    -

     

    Non-cash fair value adjustments

     

    0.27

     

     

    0.01

     

     

    0.63

     

     

    -

     

    Tax rate changes and other

     

    0.01

     

     

    (0.26

    )

     

    0.01

     

     

    (0.27

    )

    Debt refinancing and unutilized financing costs

     

    -

     

     

    -

     

     

    -

     

     

    -

     

    Normalized funds from operations

    $

    0.23

     

    $

    0.48

     

    $

    0.47

     

    $

    0.85

     

     
    Certain non-cash and related recovery information:
    Share-based compensation

    $

    0.01

     

    $

    0.02

     

    $

    0.03

     

    $

    0.04

     

    Debt costs amortization

    $

    0.01

     

    $

    0.01

     

    $

    0.02

     

    $

    0.02

     

    Non-cash rent and interest revenue (A)

    $

    -

     

    $

    (0.22

    )

    $

    -

     

    $

    (0.25

    )

    Cash recoveries of non-cash rent and interest revenue (B)

    $

    -

     

    $

    -

     

    $

    0.01

     

    $

    0.06

     

    Straight-line rent revenue from operating and finance leases

    $

    (0.07

    )

    $

    (0.10

    )

    $

    (0.15

    )

    $

    (0.21

    )

    Notes:

    Investors and analysts following the real estate industry utilize funds from operations ("FFO") as a supplemental performance measure. FFO, reflecting the assumption that real estate asset values rise or fall with market conditions, principally adjusts for the effects of GAAP depreciation and amortization of real estate assets, which assumes that the value of real estate diminishes predictably over time. We compute FFO in accordance with the definition provided by the National Association of Real Estate Investment Trusts, or Nareit, which represents net income (loss) (computed in accordance with GAAP), excluding gains (losses) on sales of real estate and impairment charges on real estate assets, plus real estate depreciation and amortization, including amortization related to in-place lease intangibles, and after adjustments for unconsolidated partnerships and joint ventures.

    In addition to presenting FFO in accordance with the Nareit definition, we disclose normalized FFO, which adjusts FFO for items that relate to unanticipated or non-core events or activities or accounting changes that, if not noted, would make comparison to prior period results and market expectations less meaningful to investors and analysts. We believe that the use of FFO, combined with the required GAAP presentations, improves the understanding of our operating results among investors and the use of normalized FFO makes comparisons of our operating results with prior periods and other companies more meaningful. While FFO and normalized FFO are relevant and widely used supplemental measures of operating and financial performance of REITs, they should not be viewed as a substitute measure of our operating performance since the measures do not reflect either depreciation and amortization costs or the level of capital expenditures and leasing costs (if any not paid by our tenants) to maintain the operating performance of our properties, which can be significant economic costs that could materially impact our results of operations. FFO and normalized FFO should not be considered an alternative to net income (loss) (computed in accordance with GAAP) as indicators of our results of operations or to cash flow from operating activities (computed in accordance with GAAP) as an indicator of our liquidity.

    Certain line items above (such as depreciation and amortization) include our share of such income/expense from unconsolidated joint ventures. These amounts are included with all activity of our equity interests in the "(Loss) earnings from equity interests" line on the consolidated statements of income.

    (A) Includes revenue accrued during the period but not received in cash, such as deferred rent, payment-in-kind ("PIK") interest or other accruals.

    (B) Includes cash received to satisfy previously accrued non-cash revenue, such as the cash receipt of previously deferred rent or PIK interest.

    View source version on businesswire.com: https://www.businesswire.com/news/home/20240807354979/en/

    Get the next $MPW alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $MPW

    DatePrice TargetRatingAnalyst
    3/12/2025$5.00 → $9.00Neutral → Outperform
    Exane BNP Paribas
    9/13/2024$6.50Neutral → Buy
    Colliers Securities
    7/2/2024$4.00Outperform → Neutral
    Exane BNP Paribas
    4/17/2024$5.00Sell → Hold
    Deutsche Bank
    4/10/2024$10.00 → $4.25Buy → Neutral
    Colliers Securities
    3/1/2024$6.00Neutral → Outperform
    Exane BNP Paribas
    1/30/2024$2.00Sell
    Deutsche Bank
    1/5/2024Overweight → Sector Weight
    KeyBanc Capital Markets
    More analyst ratings

    $MPW
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Stewart Michael G sold $296,180 worth of shares (59,000 units at $5.02), decreasing direct ownership by 27% to 157,100 units (SEC Form 4)

    4 - MEDICAL PROPERTIES TRUST INC (0001287865) (Issuer)

    11/21/25 5:30:04 PM ET
    $MPW
    Real Estate Investment Trusts
    Real Estate

    Chairman, President & CEO Aldag Edward K Jr gifted 194,600 shares, decreasing direct ownership by 4% to 5,079,412 units (SEC Form 4)

    4 - MEDICAL PROPERTIES TRUST INC (0001287865) (Issuer)

    11/20/25 5:30:03 PM ET
    $MPW
    Real Estate Investment Trusts
    Real Estate

    Chairman, President & CEO Aldag Edward K Jr covered exercise/tax liability with 80,644 shares, decreasing direct ownership by 2% to 5,274,012 units (SEC Form 4)

    4 - MEDICAL PROPERTIES TRUST INC (0001287865) (Issuer)

    10/7/25 7:00:10 PM ET
    $MPW
    Real Estate Investment Trusts
    Real Estate

    $MPW
    SEC Filings

    View All

    SEC Form SCHEDULE 13G filed by Medical Properties Trust Inc.

    SCHEDULE 13G - MEDICAL PROPERTIES TRUST INC (0001287865) (Subject)

    11/10/25 8:41:32 AM ET
    $MPW
    Real Estate Investment Trusts
    Real Estate

    SEC Form 10-Q filed by Medical Properties Trust Inc.

    10-Q - MEDICAL PROPERTIES TRUST INC (0001287865) (Filer)

    11/7/25 4:07:51 PM ET
    $MPW
    Real Estate Investment Trusts
    Real Estate

    SEC Form 8-K filed by Medical Properties Trust Inc.

    8-K - MEDICAL PROPERTIES TRUST INC (0001287865) (Filer)

    10/30/25 8:36:14 AM ET
    $MPW
    Real Estate Investment Trusts
    Real Estate

    $MPW
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Senior VP, Controller & CAO Hanna James Kevin bought $42,613 worth of shares (7,411 units at $5.75), increasing direct ownership by 2% to 372,338 units (SEC Form 4)

    4 - MEDICAL PROPERTIES TRUST INC (0001287865) (Issuer)

    3/6/25 4:37:27 PM ET
    $MPW
    Real Estate Investment Trusts
    Real Estate

    Director Pitman Elizabeth N bought $48,603 worth of shares (8,087 units at $6.01), increasing direct ownership by 12% to 76,740 units (SEC Form 4)

    4 - MEDICAL PROPERTIES TRUST INC (0001287865) (Issuer)

    9/19/24 6:01:37 PM ET
    $MPW
    Real Estate Investment Trusts
    Real Estate

    $MPW
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    National Healthcare Properties Announces Andrew T. Babin as Chief Financial Officer

    NEW YORK, Nov. 18, 2025 (GLOBE NEWSWIRE) -- National Healthcare Properties, Inc. (NASDAQ:NHPAP) ("NHP") announced today the appointment of Andrew T. Babin as Chief Financial Officer and Treasurer effective on November 18, 2025, following the resignation of Scott M. Lappetito, who has resigned effective as of such date to pursue other opportunities. "We are pleased to welcome Drew to National Healthcare Properties," stated Michael Anderson, Chief Executive Officer and President. "Drew has long demonstrated success across senior buy-side, sell-side and corporate roles throughout his career and brings with him financial, capital markets and investor relations expertise and strong relationshi

    11/18/25 4:30:00 PM ET
    $MPW
    Real Estate Investment Trusts
    Real Estate

    Medical Properties Trust Increases Regular Quarterly Dividend

    Board of Directors declares quarterly dividend of $0.09 per common share, an increase of 12% from last quarter Medical Properties Trust, Inc. (the "Company" or "MPT") (NYSE:MPW) today announced that its Board of Directors declared a regular quarterly cash dividend of $0.09 per share of common stock to be paid on January 8, 2026, to stockholders of record on December 11, 2025. Edward K. Aldag, Jr., Chairman, President, and Chief Executive Officer, said, "This dividend increase reflects our growing confidence in the strength of our portfolio and cash flow potential in the year ahead. Together with our recently announced $150 million common stock repurchase program, we are well positioned

    11/17/25 8:30:00 AM ET
    $MPW
    Real Estate Investment Trusts
    Real Estate

    Medical Properties Trust, Inc. Reports Third Quarter Results and Other Updates

    Continues Scheduled Increase in Cash Rents from New Operators Announces $150 Million Strategic Common Stock Repurchase Program Medical Properties Trust, Inc. (the "Company" or "MPT") (NYSE:MPW) today announced financial and operating results for the third quarter ended September 30, 2025, as well as certain events occurring subsequent to quarter end. Net loss of ($0.13) and Normalized Funds from Operations ("NFFO") of $0.13 for the 2025 third quarter on a per share basis. Third quarter net loss includes approximately $82 million ($0.14 per share) in impairment charges primarily related to certain Prospect Medical Group ("Prospect") bankruptcy transactions; Cash rents from MPT's ne

    10/30/25 8:00:00 AM ET
    $MPW
    Real Estate Investment Trusts
    Real Estate

    $MPW
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Medical Properties Trust upgraded by Exane BNP Paribas with a new price target

    Exane BNP Paribas upgraded Medical Properties Trust from Neutral to Outperform and set a new price target of $9.00 from $5.00 previously

    3/12/25 7:29:27 AM ET
    $MPW
    Real Estate Investment Trusts
    Real Estate

    Medical Properties Trust upgraded by Colliers Securities with a new price target

    Colliers Securities upgraded Medical Properties Trust from Neutral to Buy and set a new price target of $6.50

    9/13/24 7:35:27 AM ET
    $MPW
    Real Estate Investment Trusts
    Real Estate

    Medical Properties Trust downgraded by Exane BNP Paribas with a new price target

    Exane BNP Paribas downgraded Medical Properties Trust from Outperform to Neutral and set a new price target of $4.00

    7/2/24 7:49:27 AM ET
    $MPW
    Real Estate Investment Trusts
    Real Estate

    $MPW
    Financials

    Live finance-specific insights

    View All

    Medical Properties Trust Increases Regular Quarterly Dividend

    Board of Directors declares quarterly dividend of $0.09 per common share, an increase of 12% from last quarter Medical Properties Trust, Inc. (the "Company" or "MPT") (NYSE:MPW) today announced that its Board of Directors declared a regular quarterly cash dividend of $0.09 per share of common stock to be paid on January 8, 2026, to stockholders of record on December 11, 2025. Edward K. Aldag, Jr., Chairman, President, and Chief Executive Officer, said, "This dividend increase reflects our growing confidence in the strength of our portfolio and cash flow potential in the year ahead. Together with our recently announced $150 million common stock repurchase program, we are well positioned

    11/17/25 8:30:00 AM ET
    $MPW
    Real Estate Investment Trusts
    Real Estate

    Medical Properties Trust, Inc. Reports Third Quarter Results and Other Updates

    Continues Scheduled Increase in Cash Rents from New Operators Announces $150 Million Strategic Common Stock Repurchase Program Medical Properties Trust, Inc. (the "Company" or "MPT") (NYSE:MPW) today announced financial and operating results for the third quarter ended September 30, 2025, as well as certain events occurring subsequent to quarter end. Net loss of ($0.13) and Normalized Funds from Operations ("NFFO") of $0.13 for the 2025 third quarter on a per share basis. Third quarter net loss includes approximately $82 million ($0.14 per share) in impairment charges primarily related to certain Prospect Medical Group ("Prospect") bankruptcy transactions; Cash rents from MPT's ne

    10/30/25 8:00:00 AM ET
    $MPW
    Real Estate Investment Trusts
    Real Estate

    Medical Properties Trust Announces Third Quarter 2025 Financial Results Conference Call and Webcast

    Medical Properties Trust, Inc. (the "Company" or "MPT") (NYSE:MPW) today announced it will host a conference call and webcast on Thursday, October 30, 2025, at 11:00 a.m. Eastern Time to discuss the company's third quarter 2025 financial results. A press release with third quarter 2025 financial results will be issued before the market opens on October 30, 2025. The dial-in numbers for the conference call are 800-715-9871 (North America) and 646-307-1963 (International) and the passcode is 6695005 to join the conference. Call participants are encouraged to dial in 10-15 minutes early to ensure registration is completed prior to the start of the conference. The conference call will also be

    10/23/25 4:15:00 PM ET
    $MPW
    Real Estate Investment Trusts
    Real Estate

    $MPW
    Leadership Updates

    Live Leadership Updates

    View All

    National Healthcare Properties Announces Andrew T. Babin as Chief Financial Officer

    NEW YORK, Nov. 18, 2025 (GLOBE NEWSWIRE) -- National Healthcare Properties, Inc. (NASDAQ:NHPAP) ("NHP") announced today the appointment of Andrew T. Babin as Chief Financial Officer and Treasurer effective on November 18, 2025, following the resignation of Scott M. Lappetito, who has resigned effective as of such date to pursue other opportunities. "We are pleased to welcome Drew to National Healthcare Properties," stated Michael Anderson, Chief Executive Officer and President. "Drew has long demonstrated success across senior buy-side, sell-side and corporate roles throughout his career and brings with him financial, capital markets and investor relations expertise and strong relationshi

    11/18/25 4:30:00 PM ET
    $MPW
    Real Estate Investment Trusts
    Real Estate

    Super Micro Computer and Deckers Outdoor Set to Join S&P 500; Others to Join S&P 100, S&P MidCap 400 and S&P SmallCap 600

    NEW YORK, March 1, 2024 /PRNewswire/ -- S&P Dow Jones Indices ("S&P DJI") will make the following changes to the S&P 500, S&P 100, S&P MidCap 400, and S&P SmallCap 600 indices effective prior to the open of trading on Monday, March 18, to coincide with the quarterly rebalance. The changes ensure each index is more representative of its market capitalization range. All companies being added to the S&P 500 are more representative of the large-cap market space, all companies being added to the S&P MidCap 400 are more representative of the mid-cap market space, and all companies being added to the S&P SmallCap 600 are more representative of the small-cap market space. The companies being removed

    3/1/24 6:47:00 PM ET
    $AIT
    $AL
    $APPS
    Industrial Specialties
    Consumer Discretionary
    Diversified Commercial Services
    Multi-Sector Companies

    Medical Properties Trust, Inc.: Please contact the Portnoy Law Firm to recover your losses; November 28, 2023 deadline

    Investors can contact the law firm at no cost to learn more about recovering their losses ​LOS ANGELES, Nov. 13, 2023 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises Medical Properties Trust, Inc. ("MPW" or the "Company") (NYSE:MPW) investors that a lawsuit filed on behalf of investors that purchased MPW during the class period. Investors are encouraged to contact attorney Lesley F. Portnoy, by phone 844-767-8529 or email: [email protected], to discuss their legal rights, or click here to join the case via www.portnoylaw.com. The Portnoy Law Firm can provide a complimentary case evaluation and discuss investors' options for pursuing claims to recover their losses. In May 2023

    11/13/23 7:04:19 PM ET
    $MPW
    Real Estate Investment Trusts
    Real Estate

    $MPW
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G filed by Medical Properties Trust Inc.

    SC 13G - MEDICAL PROPERTIES TRUST INC (0001287865) (Subject)

    10/24/24 11:30:20 AM ET
    $MPW
    Real Estate Investment Trusts
    Real Estate

    SEC Form SC 13G/A filed by Medical Properties Trust Inc. (Amendment)

    SC 13G/A - MEDICAL PROPERTIES TRUST INC (0001287865) (Subject)

    1/30/24 11:16:19 AM ET
    $MPW
    Real Estate Investment Trusts
    Real Estate

    SEC Form SC 13G/A filed by Medical Properties Trust Inc. (Amendment)

    SC 13G/A - MEDICAL PROPERTIES TRUST INC (0001287865) (Subject)

    2/3/23 12:23:07 PM ET
    $MPW
    Real Estate Investment Trusts
    Real Estate